News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,358 Results
Type
Article (43047)
Company Profile (440)
Press Release (672871)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (209020)
Career Advice (2133)
Deals (36049)
Drug Delivery (104)
Drug Development (83635)
Employer Resources (178)
FDA (16449)
Job Trends (15153)
News (353319)
Policy (33150)
Tag
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (8)
Academia (2653)
Accelerated approval (6)
Adcomms (24)
Allergies (87)
Alliances (51041)
ALS (94)
Alzheimer's disease (1431)
Antibody-drug conjugate (ADC) (139)
Approvals (16440)
Artificial intelligence (268)
Autoimmune disease (25)
Automation (16)
Bankruptcy (373)
Best Places to Work (11871)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (331)
Bladder cancer (82)
Brain cancer (27)
Breast cancer (287)
Cancer (2316)
Cardiovascular disease (187)
Career advice (1788)
Career pathing (30)
CAR-T (157)
Cell therapy (444)
Cervical cancer (19)
Clinical research (67816)
Collaboration (877)
Compensation (532)
Complete response letters (24)
COVID-19 (2652)
CRISPR (45)
C-suite (252)
Cystic fibrosis (105)
Data (2232)
Decentralized trials (2)
Denatured (28)
Depression (50)
Diabetes (275)
Diagnostics (6437)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (127)
Drug pricing (107)
Drug shortages (26)
Duchenne muscular dystrophy (100)
Earnings (87867)
Editorial (40)
Employer branding (22)
Employer resources (151)
Events (116137)
Executive appointments (743)
FDA (17717)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (783)
Gene editing (113)
Generative AI (20)
Gene therapy (328)
GLP-1 (750)
Government (4516)
Grass and pollen (4)
Guidances (59)
Healthcare (19222)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (130)
Indications (30)
Infectious disease (2797)
Inflammatory bowel disease (143)
Inflation Reduction Act (11)
Influenza (52)
Intellectual property (98)
Interviews (351)
IPO (16798)
IRA (43)
Job creations (3727)
Job search strategy (1514)
Kidney cancer (10)
Labor market (38)
Layoffs (498)
Leadership (18)
Legal (8011)
Liver cancer (76)
Lung cancer (328)
Lymphoma (155)
Machine learning (7)
Management (59)
Manufacturing (313)
MASH (69)
Medical device (13553)
Medtech (13558)
Mergers & acquisitions (19790)
Metabolic disorders (719)
Multiple sclerosis (82)
NASH (19)
Neurodegenerative disease (102)
Neuropsychiatric disorders (33)
Neuroscience (2002)
NextGen: Class of 2025 (6797)
Non-profit (4582)
Northern California (2700)
Now hiring (39)
Obesity (386)
Opinion (227)
Ovarian cancer (77)
Pain (89)
Pancreatic cancer (84)
Parkinson's disease (155)
Partnered (21)
Patents (236)
Patient recruitment (111)
Peanut (47)
People (58771)
Pharmaceutical (88)
Pharmacy benefit managers (19)
Phase I (21305)
Phase II (29918)
Phase III (22133)
Pipeline (1209)
Policy (146)
Postmarket research (2605)
Preclinical (9145)
Press Release (67)
Prostate cancer (110)
Psychedelics (37)
Radiopharmaceuticals (263)
Rare diseases (404)
Real estate (6034)
Recruiting (69)
Regulatory (22771)
Reports (46)
Research institute (2421)
Resumes & cover letters (355)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (76)
Series A (139)
Series B (90)
Service/supplier (11)
Sickle cell disease (57)
Southern California (2329)
Special edition (17)
Spinal muscular atrophy (153)
Sponsored (31)
Startups (3766)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (39)
The Weekly (48)
United States (23632)
Vaccines (708)
Venture capitalists (43)
Weight loss (256)
Women's health (37)
Worklife (18)
Date
Today (164)
Last 7 days (867)
Last 30 days (2689)
Last 365 days (33880)
2025 (10885)
2024 (36324)
2023 (41050)
2022 (52302)
2021 (56806)
2020 (55010)
2019 (47550)
2018 (35833)
2017 (33096)
2016 (32465)
2015 (38517)
2014 (32299)
2013 (27230)
2012 (29349)
2011 (29975)
2010 (28068)
Location
Africa (758)
Alabama (58)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (39385)
Australia (6572)
California (6241)
Canada (2022)
China (534)
Colorado (272)
Connecticut (286)
Delaware (149)
Europe (86126)
Florida (910)
Georgia (206)
Idaho (57)
Illinois (552)
India (25)
Indiana (312)
Iowa (12)
Japan (163)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (908)
Massachusetts (4739)
Michigan (221)
Minnesota (396)
Mississippi (2)
Missouri (82)
Montana (29)
Nebraska (25)
Nevada (63)
New Hampshire (67)
New Jersey (1756)
New Mexico (30)
New York (1759)
North Carolina (1033)
North Dakota (8)
Northern California (2700)
Ohio (206)
Oklahoma (14)
Oregon (38)
Pennsylvania (1389)
Puerto Rico (12)
Rhode Island (34)
South America (1136)
South Carolina (22)
South Dakota (1)
Southern California (2329)
Tennessee (101)
Texas (923)
Utah (183)
Virginia (149)
Washington D.C. (63)
Washington State (573)
West Virginia (3)
Wisconsin (55)
716,358 Results for "walking fish therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Walking Fish Therapeutics Expands Leadership Team
Walking Fish Therapeutics, a leader in B cell engineering, announced the promotion of Julie Kim, PharmD, MS, to Chief Business Officer.
June 1, 2023
·
3 min read
Business
MaxCyte Signs Strategic Platform License with Walking Fish Therapeutics to Support the Development of its Innovative B Cell Platform
MaxCyte, Inc. today announced the signing of a strategic platform license (SPL) with Walking Fish Therapeutics , Inc. a biotechnology company that is rapidly advancing B cell-based therapeutics.
May 4, 2023
·
3 min read
BioCapital
Medical-Fish-Skin Company Kerecis Expands Silicone Fish-Skin Combination Product Range
Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection, announced the availability of Shield Standard, which combines a fish-skin graft and silicone backing for efficient treatment of acute and chronic wounds.
February 15, 2024
·
3 min read
BioMidwest
Kerecis to Present Scientific and Clinical Updates on Fish-Skin Grafts at the Symposium on Advanced Wound Care Spring
Kerecis, the pioneer in the use of fish skin and fatty acids for tissue regeneration and protection, will unveil its latest scientific and clinical updates, including trial results, at the upcoming Symposium on Advanced Wound Care Spring.
May 14, 2024
·
7 min read
Press Releases
CMS Confirms Coverage of Kerecis Fish-Skin Products by Medicare
November 15, 2024
·
3 min read
Biotech Bay
Walking Fish Therapeutics Closes $73 Million Series A Financing
Walking Fish Therapeutics , a leader in B cell therapeutics, today announced the completion of an oversubscribed Series A financing, raising a total of $73 million.
February 16, 2022
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Business
Walking Fish Therapeutics Expands Leadership Team and Debuts New Headquarters as it Advances Its B Cell Therapeutics Towards Clinical Trials
Walking Fish Therapeutics, a leader in B cell engineering, announced it has appointed Georgia Erbez as Chief Operating Officer and moved to a new 22,000 square foot office and world-class laboratory in South San Francisco.
September 6, 2022
·
1 min read
Press Releases
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
April 3, 2025
·
4 min read
Press Releases
Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update
April 30, 2025
·
8 min read
1 of 71,636
Next
